Literature DB >> 19587372

Lyn, PKC-delta, SHIP-1 interactions regulate GPVI-mediated platelet-dense granule secretion.

Ramya Chari1, Soochong Kim, Swaminathan Murugappan, Archana Sanjay, James L Daniel, Satya P Kunapuli.   

Abstract

Protein kinase C-delta (PKC-delta) is expressed in platelets and activated downstream of protease-activated receptors (PARs) and glycoprotein VI (GPVI) receptors. We have previously shown that PKC-delta positively regulates PAR-mediated dense granule secretion, whereas it negatively regulates GPVI-mediated dense granule secretion. We further investigated the mechanism of such differential regulation of dense granule release by PKC-delta in platelets. SH2 domain-containing inositol phosphatase-1 (SHIP-1) is phosphorylated on Y1020, a marker for its activation, upon stimulation of human platelets with PAR agonists SFLLRN and AYPGKF or GPVI agonist convulxin. GPVI-mediated SHIP-1 phosphorylation occurred rapidly at 15 seconds, whereas PAR-mediated phosphorylation was delayed, occurring at 1 minute. Lyn and SHIP-1, but not SHIP-2 or Shc, preferentially associated with PKC-delta on stimulation of platelets with a GPVI agonist, but not with a PAR agonist. In PKC-delta-null murine platelets, convulxin-induced SHIP-1 phosphorylation was inhibited. Furthermore, in Lyn null murine platelets, GPVI-mediated phosphorylations on Y-1020 of SHIP-1 and Y311 of PKC-delta were inhibited. In murine platelets lacking Lyn or SHIP-1, GPVI-mediated dense granule secretions are potentiated, whereas PAR-mediated dense granule secretions are inhibited. Therefore, we conclude that Lyn-mediated phosphorylations of PKC-delta and SHIP-1 and their associations negatively regulate GPVI-mediated dense granule secretion in platelets.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19587372      PMCID: PMC2756209          DOI: 10.1182/blood-2008-11-188516

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  43 in total

Review 1.  SHIPs ahoy.

Authors:  G Krystal; J E Damen; C D Helgason; M Huber; M R Hughes; J Kalesnikoff; V Lam; P Rosten; M D Ware; S Yew; R K Humphries
Journal:  Int J Biochem Cell Biol       Date:  1999-10       Impact factor: 5.085

Review 2.  Structure, function, and biology of SHIP proteins.

Authors:  L R Rohrschneider; J F Fuller; I Wolf; Y Liu; D M Lucas
Journal:  Genes Dev       Date:  2000-03-01       Impact factor: 11.361

3.  Protein kinase C[delta] differentially regulates platelet functional responses.

Authors:  Ramya Chari; Todd Getz; Bela Nagy; Kamala Bhavaraju; Yingying Mao; Yamini Saraswathy Bynagari; Swaminathan Murugappan; Keiko Nakayama; Satya P Kunapuli
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-02-12       Impact factor: 8.311

4.  Increased expression of genes linked to FcepsilonRI Signaling and to cytokine and chemokine production in Lyn-deficient mast cells.

Authors:  Valerie Hernandez-Hansen; Julie D J Bard; Christy A Tarleton; Julie A Wilder; Clifford A Lowell; Bridget S Wilson; Janet M Oliver
Journal:  J Immunol       Date:  2005-12-15       Impact factor: 5.422

5.  pp60c-src associates with the SH2-containing inositol-5-phosphatase SHIP1 and is involved in its tyrosine phosphorylation downstream of alphaIIbbeta3 integrin in human platelets.

Authors:  S Giuriato; S Bodin; C Erneux; R Woscholski; M Plantavid; H Chap; B Payrastre
Journal:  Biochem J       Date:  2000-05-15       Impact factor: 3.857

6.  SHIP's C-terminus is essential for its hydrolysis of PIP3 and inhibition of mast cell degranulation.

Authors:  J E Damen; M D Ware; J Kalesnikoff; M R Hughes; G Krystal
Journal:  Blood       Date:  2001-03-01       Impact factor: 22.113

7.  Coincident regulation of PKCdelta in human platelets by phosphorylation of Tyr311 and Tyr565 and phospholipase C signalling.

Authors:  Kellie J Hall; Matthew L Jones; Alastair W Poole
Journal:  Biochem J       Date:  2007-09-15       Impact factor: 3.857

8.  PKCdelta and cofilin activation affects peripheral actin reorganization and cell-cell contact in cells expressing integrin alpha5 but not its tailless mutant.

Authors:  Min-A Oh; Eun-Sil Kang; Sin-Ae Lee; Eun-Ok Lee; Yong-Bae Kim; Sung-Hoon Kim; Jung Weon Lee
Journal:  J Cell Sci       Date:  2007-08-01       Impact factor: 5.285

9.  Protein kinase C delta negatively regulates tyrosine hydroxylase activity and dopamine synthesis by enhancing protein phosphatase-2A activity in dopaminergic neurons.

Authors:  Danhui Zhang; Arthi Kanthasamy; Yongjie Yang; Vellareddy Anantharam; Anumantha Kanthasamy
Journal:  J Neurosci       Date:  2007-05-16       Impact factor: 6.167

10.  Deficiency of Src homology 2 domain-containing inositol 5-phosphatase 1 affects platelet responses and thrombus growth.

Authors:  Sonia Séverin; Marie-Pierre Gratacap; Nadège Lenain; Laetitia Alvarez; Etienne Hollande; Josef M Penninger; Christian Gachet; Monique Plantavid; Bernard Payrastre
Journal:  J Clin Invest       Date:  2007-03-08       Impact factor: 14.808

View more
  23 in total

Review 1.  Phosphorylation mechanisms in intensive care medicine.

Authors:  Erica L Martin; V Marco Ranieri
Journal:  Intensive Care Med       Date:  2010-09-04       Impact factor: 17.440

2.  Diacylglycerol kinase ζ is a negative regulator of GPVI-mediated platelet activation.

Authors:  Alyssa J Moroi; Nicole M Zwifelhofer; Matthew J Riese; Debra K Newman; Peter J Newman
Journal:  Blood Adv       Date:  2019-04-09

3.  Overexpression of the autoimmunity-associated phosphatase PTPN22 promotes survival of antigen-stimulated CLL cells by selectively activating AKT.

Authors:  Roberto Negro; Stefania Gobessi; Pablo G Longo; Yantao He; Zhong-Yin Zhang; Luca Laurenti; Dimitar G Efremov
Journal:  Blood       Date:  2012-05-08       Impact factor: 22.113

4.  Inhibiting tyrosine phosphorylation of protein kinase Cδ (PKCδ) protects the salivary gland from radiation damage.

Authors:  Sten M Wie; Tariq S Adwan; James DeGregori; Steven M Anderson; Mary E Reyland
Journal:  J Biol Chem       Date:  2014-02-25       Impact factor: 5.157

5.  CD2AP/SHIP1 complex positively regulates plasmacytoid dendritic cell receptor signaling by inhibiting the E3 ubiquitin ligase Cbl.

Authors:  Musheng Bao; Shino Hanabuchi; Valeria Facchinetti; Qiumei Du; Laura Bover; Joel Plumas; Laurence Chaperot; Wei Cao; Jun Qin; Shao-Cong Sun; Yong-Jun Liu
Journal:  J Immunol       Date:  2012-06-15       Impact factor: 5.422

6.  Novel phosphatidylethanolamine derivatives accumulate in circulation in hyperlipidemic ApoE-/- mice and activate platelets via TLR2.

Authors:  Sudipta Biswas; Liang Xin; Soumya Panigrahi; Alejandro Zimman; Hua Wang; Valentin P Yakubenko; Tatiana V Byzova; Robert G Salomon; Eugene A Podrez
Journal:  Blood       Date:  2016-03-25       Impact factor: 22.113

7.  The BCR-ABL inhibitor ponatinib inhibits platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling, platelet activation and aggregate formation under shear.

Authors:  Cassandra P Loren; Joseph E Aslan; Rachel A Rigg; Marie S Nowak; Laura D Healy; András Gruber; Brian J Druker; Owen J T McCarty
Journal:  Thromb Res       Date:  2014-11-18       Impact factor: 3.944

8.  CGX1037 is a novel PKC isoform delta selective inhibitor in platelets.

Authors:  Dheeraj Bhavanasi; John C Kostyak; John Swindle; Laurie E Kilpatrick; Satya P Kunapuli
Journal:  Platelets       Date:  2014-01-16       Impact factor: 3.862

9.  Reactive oxygen species play a critical role in collagen-induced platelet activation via SHP-2 oxidation.

Authors:  Ji Yong Jang; Ji Hyun Min; Yun Hee Chae; Jin Young Baek; Su Bin Wang; Su Jin Park; Goo Taeg Oh; Sang-Hak Lee; Ye-Shih Ho; Tong-Shin Chang
Journal:  Antioxid Redox Signal       Date:  2014-01-30       Impact factor: 8.401

10.  Tyrosine phosphorylation on spleen tyrosine kinase (Syk) is differentially regulated in human and murine platelets by protein kinase C isoforms.

Authors:  Lorena Buitrago; Dheeraj Bhavanasi; Carol Dangelmaier; Bhanu Kanth Manne; Rachit Badolia; Alessandra Borgognone; Alexander Y Tsygankov; Steven E McKenzie; Satya P Kunapuli
Journal:  J Biol Chem       Date:  2013-08-19       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.